Skip to content
Tuesday 8 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,822.13
-0.08%
DAX
26,006.53
-0.15%
CAC 40
8,306.15
+0.33%
STOXX 50
6,403.99
+0.17%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 31 October 2012 8:39 pm  |  Updated:  Thursday 30 May 2019 11:18 am

Bad day for BG Group and Barclays helps send FTSE 100 into the red

By: KCS-content

Add as a preferred source on Google

UK shares fell yesterday, ending the month on a down note as a string of gloomy earnings and outlooks from firms such as Barclays and GlaxoSmithKline weighed on sentiment.

The FTSE 100 was down 1.2 per cent, or 67 points, at 5,782.70 at the close, more than shedding the previous session’s gains, led down by a forecast of no growth in production next year from BG Group.

The oil and gas firm’s stock slid 13.7 per cent in heavy volume of 16 times its 90-day average, taking 24 points off the FTSE 100. Although the results came in ahead of consensus estimates, the company saw a weaker outlook.

BG’s results are an example of a broader trend where beating expected earnings is not enough to satisfy the markets.

“Earnings estimates have come down 14 per cent this year, so all the earnings growth that you were supposed to be generating in stocks this year is gone,” said Mike Ingram at BGC Partners.

Several heavyweight firms who missed estimated results yesterday also saw bleak outlooks in the near future. Barclays shed 4.7 per cent after its third-quarter profits fell by a fifth due to charges for mis-selling insurance. The bank also said that US authorities had opened two new investigations against it.

Pharmaceutical company GlaxoSmithKline lost 2.4 per cent after posting a fourth consecutive quarter in which Britain’s biggest drugmaker missed sales and earnings expectations.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Money

Related Topics

  • NULL

Trending Articles

  • Iceland boss Richard Walker vows to set up shop on Falkland Islands

  • Britain ‘taxing itself to death,’ Burnham warned

  • Hedge fund billionaire Chris Rokos joins UK wealth exodus 

  • £74m for branded condoms? UK must stop spaffing cash on foreign aid

  • Don’t underestimate the free trade agreement Britain just joined

More from Morning Wire

  • ‘We have been ignored for most of our life,’ says FTSE 100’s newest bank

    Banking
    Confetti falls as executives celebrate Lion Finance Group joining the FTSE 100 at the London Stock Exchange.
  • Shipbroker shares fly on Iran war windfall

    Transport & Infrastructure
    Aerial view of a large container ship moving through deep blue ocean waters, leaving a white wake.
  • Plus500 splashes cash on investors after US expansion bears fruit

    Fintech
    Plus500 branding on a large Jumbotron scoreboard at a US sports arena, displaying game stats.
  • L&G cheers push into private credit as profit jumps

    Markets
    Legal & General is reported to be eying Natwest's pension provider.
  • Techtronic Industries Delivers Strong First Half Performance

    Business Wire
  • Balfour Beatty ups profit forecasts as it defies construction gloom

    Transport & Infrastructure
    Balfour Beatty construction site showcasing cranes, workers, and building progress against a city skyline backdrop
  • Algoma Central Corporation Reports Financial Results for the 2026 Second Quarter

    Business Wire
  • Ladbrokes-owner and Aston Martin on chopping block in FTSE reshuffle

    Markets
    Aston Martin headquarters with company logo, highlighting job cuts and financial struggles amid tariff impacts
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook